Literature DB >> 3384087

The phosphatidylcholine pathway of diacylglycerol formation stimulated by phorbol diesters occurs via phospholipase D activation.

M C Cabot1, C J Welsh, H T Cao, H Chabbott.   

Abstract

Agonist-induced degradation of phosphatidylcholine (PC) is of interest as this pathway of diacylglycerol (DG) generation may provide added opportunities for the regulation of protein kinase C (PKC). In REF52 cells [3H]myristic acid is preferentially incorporated into PC; this, coupled with the use of [3H]choline, allows for quantitation of both the water-soluble and the lipid products generated when PC is degraded. In cells prelabeled with [3H]choline, TPA stimulated a time-dependent release, into the medium, of choline and not phosphocholine or glycerophosphocholine. Treatment of [3H]myristic acid-labeled cells with either phorbol diesters, sn-1,2-dioctanoylglycerol, or vasopressin elicited the formation of labeled phosphatidate (PA) and DG. The temporal pattern of PC hydrolysis in cells treated with TPA is indicative of a precursor (PA)-product (DG) relationship for an enzymatic sequence initiated by phospholipase D. Adding propranolol, a phosphatidate phosphohydrolase inhibitor, eliminated TPA-induced DG formation, whereas PA generation was unaffected. From these data we conclude that TPA elicits DG formation from PC by the sequential actions of phospholipase D and phosphatidate phosphohydrolase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384087     DOI: 10.1016/0014-5793(88)81374-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Involvement of PL-D in the alternate signal tranduction pathway of macrophages induced by an external stimulus.

Authors:  R Bandyopadhyay; M K Basu
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 2.  The regulation and cellular functions of phosphatidylcholine hydrolysis.

Authors:  M M Billah; J C Anthes
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

3.  Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; K McBride
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

4.  Quantitation of glycerophosphorylcholine by flow injection analysis using immobilized enzymes.

Authors:  A Mancini; F Del Rosso; R Roberti; P Caligiana; A Vecchini; L Binaglia
Journal:  Mol Cell Biochem       Date:  1996-09-20       Impact factor: 3.396

Review 5.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

6.  Stimulation of insulin release by phospholipase D. A potential role for endogenous phosphatidic acid in pancreatic islet function.

Authors:  S A Metz; M Dunlop
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

7.  Norepinephrine-induced 1,2-diacylglycerol accumulation and change in its fatty acid composition in the isolated perfused rat heart.

Authors:  K Okumura; Y Shirai; J Kondo; H Hashimoto; T Ito; K Ogawa
Journal:  Mol Cell Biochem       Date:  1990-03-27       Impact factor: 3.396

8.  The role of sphingomyelin in phosphatidylcholine metabolism in cultured human fibroblasts from control and sphingomyelin lipidosis patients and in Chinese hamster ovary cells.

Authors:  M W Spence; H W Cook; D M Byers; F B Palmer
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

9.  Vasopressin stimulates phospholipase D activity against phosphatidylcholine in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; H T Cao; H Chabbott
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

10.  Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions.

Authors:  K Yasui; A Komiyama; T F Molski; R I Sha'afi
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.